Legend Biotech (LEGN) Exchange Rate Effect (2019 - 2026)
Legend Biotech's (LEGN) quarterly Exchange Rate Effect came in at -$1.2 million in Q1 2026, down 185.71% YoY from $1.4 million in Q1 2025, and up 55.56% on a QoQ basis from -$2.7 million in Q4 2025.
Legend Biotech (LEGN) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Exchange Rate Effect data on file, last reported at -$1.2 million in Q1 2026.
- Quarterly Exchange Rate Effect fell 185.71% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 1020.44% YoY) and the FY2025 annual result came in at $6.1 million, up 390.48% from the prior year.
- Exchange Rate Effect rose to -$1.2 million in Q1 2026, from -$2.7 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $38.3 million in Q4 2023 to a low of -$2.7 million in Q4 2025.
- A 5-year average of $2.2 million and a median of -$343000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect slumped 23640.0% — and 2025, when it jumped 49244.44%.
- Tracing LEGN's Exchange Rate Effect over 5 years: stood at -$1.1 million in 2022, then surged by 3556.45% to $38.3 million in 2023, then slumped by 106.0% to -$2.3 million in 2024, then decreased by 17.39% to -$2.7 million in 2025, then surged by 55.56% to -$1.2 million in 2026.
- The last three Exchange Rate Effect figures came in at -$1.2 million (Q1 2026), -$2.7 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | -300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -300,000.00 |
| Jun 30, 2026 | -300,000.00 |
| Mar 31, 2026 | -1.20 Mn |
| Mar 31, 2026 | -1.20 Mn |
| Dec 31, 2025 | -2.70 Mn |
| Dec 31, 2025 | -2.70 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Sep 30, 2024 | 524,000.00 |
| Sep 30, 2024 | 524,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | -343,000.00 |
| Mar 31, 2024 | -343,000.00 |